ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $528,000 | -61.1% | 31,739 | -63.0% | 0.02% | -56.4% |
| Q2 2018 | $1,356,000 | +4.8% | 85,827 | -15.8% | 0.06% | +5.8% |
| Q1 2018 | $1,294,000 | +46.5% | 101,927 | +32.2% | 0.05% | +33.3% |
| Q4 2017 | $883,000 | -19.7% | 77,127 | -14.0% | 0.04% | -30.4% |
| Q3 2017 | $1,099,000 | +0.6% | 89,727 | +138.8% | 0.06% | +36.6% |
| Q4 2014 | $1,092,000 | +142.1% | 37,567 | +5.5% | 0.04% | +95.2% |
| Q3 2014 | $451,000 | – | 35,597 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |